Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trialGlenda Gray, Mookho Malahleha, Ollivier Hyrien et al.|The Lancet Infectious Diseases|2024Cited by 40
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participantsCatherine Riou, Helen Rees, Jinal N. Bhiman et al.|PLOS Global Public Health|2024Cited by 12
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participantsCatherine Riou, Helen Rees, Jinal N. Bhiman et al.|medRxiv|2023Cited by 5